Attributes | Values |
---|
rdf:type
| |
Description
| - Léčba nádorů vyvolaných buňkami transformovanými HPV16, které jsou MHC I-positivní či MHC I-negativní, kombinovanou chemo- a imunoterapií. (cs)
- Treatment of tumours induced by HPV16-transformed, either MHC-I positive or MHC-I negative cells by a combination of chemo- and immunotherapy.
- Treatment of tumours induced by HPV16-transformed, either MHC-I positive or MHC-I negative cells by a combination of chemo- and immunotherapy. (en)
|
Title
| - Chemotherapy, IL–12 gene therapy and combined adjuvant therapy of HPV16–associated MHC class I–proficient and deficient tumours
- Chemotherapy, IL–12 gene therapy and combined adjuvant therapy of HPV16–associated MHC class I–proficient and deficient tumours (en)
- Chemoterapie, genová terapie pomocí IL–12 a kombinovaná adjuvantní terapie nádorů z HPV16–transformovaných buněk, které exprimují či neexprimují MHC–I (cs)
|
skos:prefLabel
| - Chemotherapy, IL–12 gene therapy and combined adjuvant therapy of HPV16–associated MHC class I–proficient and deficient tumours
- Chemotherapy, IL–12 gene therapy and combined adjuvant therapy of HPV16–associated MHC class I–proficient and deficient tumours (en)
- Chemoterapie, genová terapie pomocí IL–12 a kombinovaná adjuvantní terapie nádorů z HPV16–transformovaných buněk, které exprimují či neexprimují MHC–I (cs)
|
skos:notation
| - RIV/00023736:_____/06:00006673!RIV09-MZ0-00023736
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(NR7807), P(NR8004), V, Z(AV0Z50520514)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00023736:_____/06:00006673
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - HPV-16 tumours; MHC I expression; chemotherapy; gene-based immunotherapy (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - International Journal of Oncology
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Vonka, Vladimír
- Indrová, M.
- Bieblová, J.
- Jandlová, T.
- Pajtasz-Pisecka, E.
- Reiniš, M.
|
http://linked.open...ain/vavai/riv/wos
| |
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |
is http://linked.open...avai/riv/vysledek
of | |